news

As the global population ages, the demand for arrhythmia diagnosis and treatment continues to rise. Combined with ongoing advances in minimally invasive medical technologies, these factors are driving a new wave of growth and technological transformation in the cardiac electrophysiology (EP) ablation market. From conventional radiofrequency (RF) and cryoablation to the rapid commercialization of pulsed field ablation (PFA), competition is evolving beyond individual energy modalities toward integrated systems combining high-density mapping, 3D navigation, real-time imaging, and precise energy control. As the industry moves toward 2027, competitive differentiation will increasingly depend not only on advances in ablation technology, but also on system-wide precision, safety, and reliability.